2010
DOI: 10.1186/1471-2407-10-379
|View full text |Cite
|
Sign up to set email alerts
|

Simultaneous gene silencing of Bcl-2, XIAP and Survivin re-sensitizes pancreatic cancer cells towards apoptosis

Abstract: BackgroundPancreatic ductal adenocarcinoma shows a distinct apoptosis resistance, which contributes significantly to the aggressive nature of this tumor and constrains the effectiveness of new therapeutic strategies. Apoptosis resistance is determined by the net balance of the cells pro-and anti-apoptotic "control mechanisms". Numerous dysregulated anti-apoptotic genes have been identified in pancreatic cancer and seem to contribute to the high anti-apoptotic buffering capacity. We aimed to compare the benefit… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
24
0

Year Published

2012
2012
2024
2024

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 40 publications
(26 citation statements)
references
References 22 publications
2
24
0
Order By: Relevance
“…Dysregulation of genes associated with the intrinsic apoptotic pathway seem to play an important role in mediating this resistance to apoptosis [24,25]. We, therefore, evaluated the expression of several important anti-apoptotic genes of the intrinsic apoptosis pathway in our PaCaDD cell lines and in the established cell lines as controls.…”
Section: Discussionmentioning
confidence: 99%
“…Dysregulation of genes associated with the intrinsic apoptotic pathway seem to play an important role in mediating this resistance to apoptosis [24,25]. We, therefore, evaluated the expression of several important anti-apoptotic genes of the intrinsic apoptosis pathway in our PaCaDD cell lines and in the established cell lines as controls.…”
Section: Discussionmentioning
confidence: 99%
“…XIAP and survivin are the most potent caspase inhibitors of all of the IAPs. They can block the intrinsic and extrinsic apoptosis pathways via binding to caspases 3, 7, and 9 [25,26]. The expressions of XIAP and survivin are dramatically up-regulated in many cancers, resulting in a poor prognosis for cancer patients [27].…”
Section: Discussionmentioning
confidence: 99%
“…Mori et al reestablished TRAIL--induced apoptosis in TRAIL--resistant cells by exposure to FLIP antisense; moreover, the effect of TRAIL was enhanced by the combination of FLIP antisense and embelin, a small inhibitor of X--linked inhibitor of apoptosis protein (XIAP) [71]. Other data support the increase of the apoptosis--sensitization of TRAIL--resistant pancreatic carcinoma cells by down--regulation of c--FLIP and XIAP [72,73,74,75]. TRAIL has a great potential for clinical application and agonistic TRAIL receptors (TRAIL--R1/R2) are being investigated as therapeutic targets.…”
Section: Dong Et Al Demonstrated Upregulation Of Bcl--2 and Decreasementioning
confidence: 96%